Weight Watchers CEO on diabetes drugs for weight loss

[Amity Island]

The popularity of drugs like Novo Nordisk's (NVO) Ozempic and Wegovy, and soon Eli Lilly's (LLY) Mounjaro, could help boost the company's membership as it looks to offer these medications — typically used for diabetes — which have been proven in clinical trials to help shed weight in addition to managing the disease.

WW CEO Sima Sistani told Yahoo Finance that this move is not a shift away from the legacy program's core beliefs in behavioral and diet changes with community support.

Weight Watchers CEO on diabetes drugs for weight loss: 'There's been a lot of misinformation and misuse'

Weight Watchers sees an opportunity to be a guide for chronic disease management in weight loss space.

uk.finance.yahoo.com

 

[mikeyB]

I don't think that this current fad for using Wegovy for weight loss will die down as soon as folk get the side effects like nausea, vomiting, diarrhoea, abdominal pain, headache, feeling bloated - and that's just the common side effects.

Plus those using it to lose weight find that the weight goes up after stopping it, which Novo Nordiisk's accountants know full well, and are just waiting for the money to roll in.